Technical Analysis for AGN - Allergan, Inc.

Grade Last Price % Change Price Change
grade F 197.78 -0.32% -0.63
AGN closed down 0.32 percent on Tuesday, October 17, 2017, on 1.94 times normal volume.

Earnings due: Nov 1

Track This Stock
Watchlist Portfolio
Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical AGN trend table...

Date Alert Name Type % Chg
Oct 17 MACD Bearish Signal Line Cross Bearish 0.00%
Oct 17 Jack-in-the-Box Bearish Bearish Swing Setup 0.00%
Oct 17 Calm After Storm Range Contraction 0.00%
Oct 16 Volume Surge Other -0.32%
Oct 16 Wide Range Bar Range Expansion -0.32%

Older signals for AGN ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio.
Basic chart:

Allergan, Inc. operates as a multi-specialty healthcare company primarily in the United States, Europe, Latin America, and the Asia Pacific. The company discovers, develops, and commercializes pharmaceutical, biological, medical device, and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatological, breast aesthetics, urological, and other specialty markets. It operates in two segments, Specialty Pharmaceuticals and Medical Devices. The Specialty Pharmaceuticals segment produces a range of pharmaceutical products, including ophthalmic products for dry eye, glaucoma, inflammation, infection, allergy, and retinal disease; Botox for certain therapeutic and aesthetic indications; skin care products for acne, psoriasis, eyelash growth, and other prescription and over-the-counter skin care products; and urologics products. The Medical Devices segment offers a range of medical devices, such as breast implants for augmentation, revision, and reconstructive surgery, as well as tissue expanders; and facial aesthetics products. The company sells its products to drug wholesalers, independent and chain drug stores, pharmacies, commercial optical chains, opticians, mass merchandisers, food stores, hospitals, group purchasing organizations, integrated direct hospital networks, ambulatory surgery centers, government purchasing agencies, and medical practitioners. It focuses on eye care professionals, neurologists, physiatrists, dermatologists, plastic and reconstructive surgeons, aesthetic specialty physicians, bariatric surgeons, urologists, and general practitioners. The company has collaboration agreements with Molecular Partners AG; Spectrum Pharmaceuticals, Inc.; and Serenity Pharmaceuticals, LLC. Allergan, Inc. was founded in 1948 and is headquartered in Irvine, California.
Is AGN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 256.0223
52 Week Low 182.8602
Average Volume 2,622,369
200-Day Moving Average 230.8031
50-Day Moving Average 218.5046
20-Day Moving Average 206.1835
10-Day Moving Average 204.72
Average True Range 5.565
ADX 19.8
+DI 16.21
-DI 35.15
Chandelier Exit (Long, 3 ATRs ) 210.845
Chandelier Exit (Short, 3 ATRs ) 208.795
Upper Bollinger Band 213.6521
Lower Bollinger Band 198.7149
Percent B (%b) -0.06
BandWidth 7.244615
MACD Line -5.2849
MACD Signal Line -5.1244
MACD Histogram -0.1605
Fundamentals Value
Market Cap 66.12 Billion
Num Shares 334 Million
EPS 32.82
Price-to-Earnings (P/E) Ratio 6.03
Price-to-Sales 4.64
Price-to-Book 0.99
PEG Ratio 1.03
Dividend 2.80
Dividend Yield 1.42%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 207.76
Resistance 3 (R3) 208.70 206.33 206.09
Resistance 2 (R2) 206.33 203.79 205.85 205.54
Resistance 1 (R1) 202.05 202.22 200.87 201.11 204.98
Pivot Point 199.68 199.68 199.08 199.20 199.68
Support 1 (S1) 195.40 197.14 194.22 194.46 190.58
Support 2 (S2) 193.03 195.57 192.55 190.02
Support 3 (S3) 188.75 193.03 189.47
Support 4 (S4) 187.81